Glyconjugate Vaccines
US-2024382585-A1 · Nov 21, 2024 · US
Methods of cell culture
US8956830B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8956830-B2 |
| Application number | US-201313829292-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2013 |
| Priority date | Mar 14, 2013 |
| Publication date | Feb 17, 2015 |
| Grant date | Feb 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using DMSO, are described.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of producing a recombinant protein preparation having target values of high mannose glycans and fucosylated glycans, the method comprising: (a) providing a mammalian cell genetically engineered to express a recombinant protein; (b) culturing the cell in a culture medium comprising dimethylsulfoxide (DMSO) under conditions in which the cell expresses the recombinant protein; and (c) harvesting a preparation of the recombinant protein produc…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C12P21/005Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8956830B2 cover?
- Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using DMSO, are described.
- Who is the assignee on this patent?
- Momenta Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification C12P21/005. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).